Medopad applies technologies like remote patient monitoring, smartphone apps and data analytics to personalized patient care.
Under the agreement, researchers affiliated with John Hopkins University’s Global mHealth Initiative and the university’s Technology Innovation Center will use Medopad’s technologies to create joint clinical and public health projects.
For example, researchers will use Medopad’s datasets to develop predictive models and clinical decision support solutions. The two organizations also hope to improve population health monitoring by developing methods for early detection of disease outbreaks.
“By combining our resources and expertise we will be able to create innovative mobile health solutions and improve patient care on a global scale,” said Dan Vahdat, co-founder and CEO of Medopad.
More articles on health IT:
NIH introduces research program on genome editing in humans
Study: White patients more likely than minorities to use web portals
Mount Sinai researchers develop speech analysis software to detect psychiatric disorders
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
